" class="no-js "lang="en-US"> Miriam Merad Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

DEM BioPharma Appoints Miriam Merad, M.D., Ph.D., to Scientific Advisory Board

DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and macrophages […]

Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist

French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more